SCHEMBL21369723

SCHEMBL21369723

c1ccc(-c2cccc(-c3cc(-c4cc(-c5ccc6c7ccccc7c7ccccc7c6c5)cc(-n5c6ccccc6c6ccc(-c7ccccc7)cc65)c4)nc(-c4ccccc4)n3)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.39
KMT2A Q03164 6/20 0.39
ALDH1A1 P00352 5/20 0.39
MAPT P10636 5/20 0.39
HPGD P15428 5/20 0.39
KDM4E B2RXH2 4/20 0.39
LMNA P02545 2/20 0.39
GLA P06280 1/20 0.39
NTSR1 P30989 1/20 0.37
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MAOB P27338 2/20 0.33
MAOA P21397 1/20 0.33
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
RXRA P19793 1/20 0.32
RXRB P28702 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21369628 0.98 MEN1 (0.40) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21369919 0.98 MEN1 (0.38) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21369784 0.97 KDM4E (0.41) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21369721 0.96 MEN1 (0.40) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21369705 0.96 MEN1 (0.40) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21370345 0.95 KDM4E (0.42) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21369925 0.95 MEN1 (0.39) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21369717 0.95 MEN1 (0.40) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21369783 0.94 KDM4E (0.39) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21369627 0.94 MEN1 (0.42) MEN1KMT2AALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190288215-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME SOULBRAIN CO., LTD. (KR) 2019-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190288215-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CYP1A1, CYP1B1 MEN1 307/4885KMT2A 1401/4885ALDH1A1 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.